Edition:
United Kingdom

Exact Sciences Corp (EXAS.OQ)

EXAS.OQ on NASDAQ Stock Exchange Capital Market

51.56USD
15 Dec 2017
Change (% chg)

-- (--)
Prev Close
$51.56
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
514,065
52-wk High
$63.60
52-wk Low
$13.06

Latest Key Developments (Source: Significant Developments)

Exact Sciences reports qtrly loss per share of $0.23
Monday, 30 Oct 2017 

Oct 30 (Reuters) - Exact Sciences Corp ::Exact Sciences Corp qtrly loss per share $0.23; qtrly revenue $72.6 million, up 158 percent.Exact Sciences Corp sees 2017 revenue of $254 million to $257 million.  Full Article

David Shaw reports 5 pct passive stake in Exact Sciences Corp - SEC filing
Thursday, 25 Aug 2016 

Exact Sciences Corp :David shaw reports 5 pct passive stake in Exact Sciences Corp - SEC filing.  Full Article

Exact Sciences files for potential mixed shelf - SEC filing
Wednesday, 27 Jul 2016 

Exact Sciences Corp :Files for potential mixed shelf - SEC filing.  Full Article

Exact Sciences posts Q2 loss per share of $0.46
Tuesday, 26 Jul 2016 

Exact Sciences Corp : Generated revenues of $21.2 million during Q2 ended June 30, 2016, representing a 161-percent increase from $8.1 million in Q2 of 2015 . Q2 loss per share $0.46 . Continues to anticipate completing more than 240,000 Cologuard tests during 2016, generating revenue of $90 to $100 million for 2016 . Q2 earnings per share view $-0.55, revenue view $18.5 million -- Thomson Reuters I/B/E/S .FY2016 revenue view $86.6 million -- Thomson Reuters I/B/E/S.  Full Article

Exact Sciences'Cologuard Included in Final USPSTF Colorectal Cancer Screening Recommendations
Wednesday, 15 Jun 2016 

: Exact Sciences' Cologuard Included in Final USPSTF Colorectal Cancer Screening Recommendations .Exact Sciences Corp says final recommendations also recognize use of cologuard every three years.  Full Article

Exact Sciences Corp announces contract with Anthem BlueCross of California
Monday, 11 Jan 2016 

Exact Sciences Corp:Says signed agreement with Anthem in California contemplates that Exact Sciences may enter into similar agreements with Anthem affiliates in other regions, and Exact Sciences intends to pursue such agreements during the first half of 2016.  Full Article

BRIEF-Exact Sciences reports qtrly loss per share of $0.23

* Exact Sciences Corp qtrly loss per share $0.23; qtrly revenue $72.6 million, up 158 percent